Segment Information (Tables)

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Schedule of Financial Information by Segment

The following tables present financial information by segment:

	Three Months Ended  March 31,
	2023		2022
Net revenue:
Products & Healthcare Services	$	1,915,489	$	2,134,041
Patient Direct	607,360		272,911
Consolidated net revenue	$	2,522,849	$	2,406,952
Operating income:
Products & Healthcare Services	$	1,820	$	89,083
Patient Direct	45,849		15,793
Acquisition-related charges and intangible amortization	(22,188)		(42,135)
Exit and realignment charges	(15,674)		(1,682)
Consolidated operating income	$	9,807	$	61,059
Depreciation and amortization:
Products & Healthcare Services	$	18,566	$	18,994
Patient Direct	52,360		5,131
Consolidated depreciation and amortization	$	70,926	$	24,125
Capital expenditures:
Products & Healthcare Services	$	6,332	$	10,643
Patient Direct	45,158		318
Consolidated capital expenditures	$	51,490	$	10,961

Schedule of Consolidated Total Assets

	March 31, 2023		December 31, 2022
Total assets:
Products & Healthcare Services	$	2,739,136	$	2,809,600
Patient Direct	2,504,227		2,507,216
Segment assets	5,243,363		5,316,816
Cash and cash equivalents	66,840		69,467
Consolidated total assets	$	5,310,203	$	5,386,283

Schedule of Revenue from External Customers and Long-lived Assets, by Geographical

The following table presents net revenue by geographic area, which were attributed based on the location from which we ship products or provide services:

	Three Months Ended March 31,
	2023		2022
Net revenue:
United States	$	2,452,936	$	2,262,019
International	69,913		144,933
Consolidated net revenue	$	2,522,849	$	2,406,952